KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.7297
+0.0563 (8.36%)
At close: Jul 30, 2026, 4:00 PM EDT
0.7100
-0.0197 (-2.70%)
After-hours: Jul 30, 2026, 7:56 PM EDT
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $13.57 million as of July 30, 2026. Its market cap has decreased by -74.97% in one year.
Market Cap
13.57M
Enterprise Value
4.80M
1-Year Change
-74.97%
Ranking
Category
Stock Price
$0.73
ChartMarket Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $13.57M, a decrease of -96.85%. That is a compound annual growth rate of -31.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 13.57M | 194.89% |
| Dec 31, 2025 | 4.60M | -85.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 13.97M |
| BioLineRx | 13.62M |
| Tempest Therapeutics | 13.21M |
| Lexaria Bioscience | 13.14M |
| SeaStar Medical Holding | 13.07M |
| Cocrystal Pharma | 12.00M |
| CalciMedica | 11.73M |
| Intensity Therapeutics | 11.70M |